American Journal of Kidney Diseases
Volume 52, Issue 3 , Pages 507-518, September 2008

The Effect of On-line High-flux Hemofiltration Versus Low-flux Hemodialysis on Mortality in Chronic Kidney Failure: A Small Randomized Controlled Trial

  • Antonio Santoro, MD

      Affiliations

    • Nephrology, Dialysis, and Hypertension Department, Policlinico S Orsola-Malpighi, Bologna, Italy
    • Corresponding Author InformationAddress correspondence to Antonio Santoro, MD, Department of Nephrology Dialysis Hypertension, Policlinico S Orsola-Malpighi, Via P Palagi 9, 40138 Bologna, Italy
  • ,
  • Elena Mancini, MD

      Affiliations

    • Nephrology, Dialysis, and Hypertension Department, Policlinico S Orsola-Malpighi, Bologna, Italy
  • ,
  • Roberto Bolzani, PhD

      Affiliations

    • Department of Psychology, University of Bologna, Bologna, Italy
  • ,
  • Rolando Boggi, MD

      Affiliations

    • Ospedale Civile, Senigallia, Ancona, Italy
  • ,
  • Leonardo Cagnoli, MD

      Affiliations

    • Ospedale degli Infermi, Rimini, Italy
  • ,
  • Angelo Francioso, MD

      Affiliations

    • Ospedale S Croce, Fano, Pesaro, Italy
  • ,
  • Maurizio Fusaroli, MD

      Affiliations

    • Ospedale S Maria delle Croci, Ravenna, Italy
  • ,
  • Valter Piazza, MD

      Affiliations

    • Fondazione Maugeri, Pavia, Italy
  • ,
  • Renato Rapanà, MD

      Affiliations

    • Ospedale S Maria della Scaletta, Imola, Bologna, Italy
  • ,
  • Giovanni F.M. Strippoli, MD

      Affiliations

    • Department of Pharmacology and Epidemiology, Mario Negri Sud Consortium, S Maria Imbaro, Chieti, Italy
    • DIAVERUM Medical-Scientific Office, Lund, Sweden

Received 26 October 2007; accepted 12 May 2008. published online 10 July 2008.

Background

Given the paucity of prospective randomized controlled trials assessing comparative performances of different dialysis techniques, we compared on-line high-flux hemofiltration (HF) with ultrapure low-flux hemodialysis (HD), assessing survival and morbidity in patients with end-stage renal disease (ESRD).

Study Design

An investigator-driven, prospective, multicenter, 3-year-follow-up, centrally randomized study with no blinding and based on the intention-to-treat principle.

Setting & Participants

Prevalent patients with ESRD (age, 16 to 80 years; vintage > 6 months) receiving renal replacement therapy at 20 Italian dialysis centers.

Interventions

Patients were centrally randomly assigned to HD (n = 32) or HF (n = 32).

Outcomes & Measurements

All-cause mortality, hospitalization rate for any cause, prevalence of dialysis hypotension, standard biochemical indexes, and nutritional status. Analyses were performed using the multivariate analysis of variance and Cox proportional hazard method.

Results

There was significant improvement in survival with HF compared with HD (78%, HF versus 57%, HD) at 3 years of follow-up after allowing for the effects of age (P = 0.05). End-of-treatment Kt/V was significantly higher with HD (1.42 ± 0.06 versus 1.07 ± 0.06 with HF), whereas β2-microglobulin levels remained constant in HD patients (33.90 ± 2.94 mg/dL at baseline and 36.90 ± 5.06 mg/dL at 3 years), but decreased significantly in HF patients (30.02 ± 3.54 mg/dL at baseline versus 23.9 ± 1.77 mg/dL; P < 0.05). The number of hospitalization events for each patient was not significantly different (2.36 ± 0.41 versus 1.94 ± 0.33 events), whereas length of stay proved to be significantly shorter in HF patients compared with HD patients (P < 0.001). End-of-treatment body mass index decreased in HD patients, but increased in HF patients. Throughout the study period, the difference in trends of intradialytic acute hypotension was statistically significant, with a clear decrease in HF (P = 0.03).

Limitations

This is a small preliminary intervention study with a high dropout rate and problematic generalizability.

Conclusion

On-line HF may improve survival independent of Kt/V in patients with ESRD, with a significant decrease in plasma β2-microglobulin levels and increased body mass index. A larger study is required to confirm these results.

Index Words: Hemodialysis, hemofiltration, high flux, dialysis adequacy

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Trial registration: www.cochrane-renal.org; study number: CRG080600082.

 Originally published online as doi:10.1053/j.ajkd.2008.05.011 on July 10, 2008.

PII: S0272-6386(08)00888-3

doi:10.1053/j.ajkd.2008.05.011

Refers to article:

  • “Artificial” Hemodialysis Versus “Natural” Hemofiltration

    Thomas A. Depner
    American Journal of Kidney Diseases September 2008 (Vol. 52, Issue 3, Pages 403-406)

American Journal of Kidney Diseases
Volume 52, Issue 3 , Pages 507-518, September 2008